'Is tinnitus accompanied by hemifacial spasm in normal-hearing patients also a type of hyperactive neurovascular compression syndrome? : A magnetoencephalography study
- Won Seok Chang†1,
- Bong Soo Kim†1,
- Ji Eun Lee1,
- Hyun Ho Jung1,
- Kiwoong Kim2,
- Hyuk Chan Kwon2,
- Yong Ho Lee2 and
- Jin Woo Chang1, 3Email author
© Chang et al.; licensee BioMed Central Ltd. 2013
Received: 19 December 2012
Accepted: 3 May 2013
Published: 8 May 2013
Traditionally, tinnitus accompanied by hemifacial spasm has been considered a type of hyperactive neurovascular compression syndrome that is similar to hemifacial spasm alone because of the anatomically close relationship between the facial nerve and cochlear nerve as well as the hyperactive clinical nature.
Participants were 29 subjects who presented with hemifacial spasm and neuroradiological evidence of vascular compression of the cranial (facial/cochlear) nerve. We used magnetoencephalography (MEG) to estimate the activity of the cochlear nerve in patients with and without tinnitus on the ipsilateral side. We compared the difference in the latency and the ratio of the equivalent current dipole (ECD) strength between the ipsilateral and contralateral sides of the spasm and tinnitus.
Cochlear nerve activity in patients with tinnitus was increased with a shorter latency (p = 0.016) and stronger ECD strength (p = 0.028) compared with patients without tinnitus.
The MEG results from normal-hearing patients who had tinnitus accompanied by hemifacial spasm suggest that the hyperactivity of the auditory central nervous system may be a crucial pathophysiological factor in the generation of tinnitus in these patients. The neurovascular compression that causes sensory input from the pathologic facial nerve activity may contribute to this hyperactivity of the central auditory nervous system.
KeywordsHemifacial spasm Magnetoencephalography Pathophysiology Tinnitus
Tinnitus is defined as the subjective perception of a sound in the absence of any physical sound source. Tinnitus may be the result of spontaneous and aberrant neural activity of the auditory system. Approximately 5-15% of the population in western societies experience chronic tinnitus for more than 6 and up to 12 months . A wide range of therapies including pharmacological and surgical intervention have been proposed for the treatment of tinnitus symptom. Because tinnitus usually coincides with various ear disorders, surgical treatment of chronic tinnitus mainly focuses on ontological surgery. However, some types of tinnitus such as pulsatile tinnitus, which can be caused by vascular compression of the auditory nerve, may require different therapeutic approaches.
Microvascular decompression surgery has been used to treat tinnitus because neurovascular compression of the cochlear nerve is assumed to be one of the causes of tinnitus. And this type of Tinnitus is similar to other neurovascular compression syndromes, such as hemifacial spasm (HFS) and trigeminal neuralgia [2–5]. Interestingly, some patients experience ipsilateral tinnitus accompanied by HFS. This type of tinnitus was encountered in 10 of 142 patients with HFS in a study by Ryu et al. . If tinnitus is accompanied by HFS, the surgical outcome following microvascular decompression has a relatively high success rate, especially in cases in which the cochlear nerve is affected [6, 7]. It has been suggested that some forms of tinnitus may be caused by neurovascular compression in the cerebellopontine angle [8, 9].
The pathophysiology of HFS has been relatively well studied . However, the pathophysiology of tinnitus is still controversial, especially if tinnitus is accompanied by HFS. To investigate the pathophysiology of tinnitus accompanied by HFS, we used magnetoencephalography (MEG) to study patients and analyzed the relationship between the presence of tinnitus and the MEG results.
Participants were 29 subjects with HFS with neuro-radiological evidence of vascular compression of cranial (facial/auditory) nerve. Inclusion criteria were as follows: 1) patients with unilateral HFS; 2) patients with tinnitus on the same side as the HFS, if the patient had tinnitus; 3) patients with a hearing level better than 20 dB at 1000 Hz and better than 25 dB at each frequency examined (250 Hz to 3000 Hz with pure tone audiometry, as measured by an otorhinolaryngologist); 4) patients without otologic disorders; 5) patients with differences in hearing levels between the left and right ear of 5 dB or less; and 6) patients who could undergo MEG and magnetic resonance imaging (MRI) procedures. The diagnosis of HFS was made according to clinical symptoms and MRI findings of vascular compression of the cranial (facial/cochlear) nerve. From January 2011 to December 2011, 29 patients met these criteria and underwent MEG.
This study was approved by the Korean Food and Drug Administration. All participants provided written informed consent, and the study was approved by the Institutional Review Board of Severance Hospital, Seoul, Korea (IRB no. 1-2011-0088).
Stimulation and MEG measurement
Tone bursts of 100-ms duration (10-ms slope) were employed for the acoustic stimulation protocol. Pure tones of 1000 Hz were applied to the patient’s left and right ear. The acoustic stimulation consisted of 100 epochs of a random inter-stimulus interval between 900 and 1000 ms. Individual hearing thresholds were determined before the stimulation. Tones were delivered at a comfortable level 40 dB above threshold through two 2.5-m long silicon tubes (ER-30, Etymotic Research, Inc., USA). Sound stimuli were generated with a STIM2 system (Compumedics Neuroscan, USA).
MEG data for all patients were recorded with a whole-head MEG system (KRISS, Daejeon, Korea) with 152 axial first-order gradiometers. Sound-triggered epochs (including a 100-ms pre-stimulus baseline) were filtered online with a bandpass of 0.1-100 Hz and recorded at a sampling rate of 1000 Hz.
The measured auditory evoked field (AEF) waveforms were filtered offline with 3–40 Hz band-pass filtering, and the neuromagnetic responses to the auditory stimuli were averaged to improve the signal-to-noise ratio. The baseline for the waveforms was defined as a mean amplitude between −100 and 0 ms relative to the tone onset.
We selected neuromagnetic data in the hemisphere contralateral to the stimulus to calculate equivalent current dipoles (ECDs) . The dipolar moment at the N100m response was used to detect the peak latency of the N100m and to explain the magnetic field patterns during the N100m (70–140 ms). The goodness-of-fit (%) of the N100m dipole was calculated and merged with the patient’s MRI to verify the anatomical location of the N100m dipole. To compare the effect of each clinical factor on the N100m latency and ECD strength, the latency difference of the N100m (the latency of the N100m on the tinnitus side − the latency of the N100m on the control side) and the ratio of the ECD strength of the N100m (the ECD strength of the N100m on the tinnitus side/the ECD strength of the N100m on the control side) were calculated.
Clinical data and MEG data were analyzed together. To compare the N100m latency and ECD strength, the latency difference of the N100m and the ratio of ECD strength of the N100m were analyzed by paired t-test and non-parametric Mann–Whitney tests. All statistical tests were performed using SPSS v.18.0 (NCSS statistical software, Kaysville, UT, USA). All statistical tests were two-tailed. The threshold for statistical significance was set at p < 0.05.
Patient demographic characteristics
Type of tinnitus
Summary of results (N100m latency)
Auditory stimulation side
(ms, mean ± S.D.)
101.3 ± 14.3
99.1 ± 10.0
92.8 ± 7.9
97.0 ± 7.1
104.5 ± 15.0
100.0 ± 10.9
98.5 ± 9.0
98.3 ± 7.4
102.0 ± 15.5
99.1 ± 10.0
104.5 ± 15.1
100.0 ± 10.9
98.9 ± 7.9
97.0 ± 7.1
95.7 ± 9.0
97.3 ± 7.8
107.3 ± 16.7
101.0 ± 11.8
Summary of results (ECD strength)
Auditory stimulation side
(nAm, mean ± S.D.)
27.5 ± 9.4
24.8 ± 11.6
30.5 ± 12.7
18.8 ± 5.1
26.4 ± 8.0
27.1 ± 12.6
27.6 ± 9.3
25.6 ± 10.4
27.5 ± 10.2
24.6 ± 12.1
30.31 ± 1.0
29.3 ± 12.4
24.6 ± 6.5
20.0 ± 9.6
26.5 ± 10.5
22.0 ± 12.4
28.7 ± 8.4
27.9 ± 10.2
The concept of a hyperactive neurovascular compression syndrome such as HFS and trigeminal neuralgia has been accepted since Dandy’s first report, and microvascular decompression for these syndromes has acceptable surgical outcomes [11–14]. Due to the anatomically close relationship between the cochlear nerve and the facial nerve, some attempts have been made to perform microvascular decompression to treat tinnitus, based on the assumption that tinnitus is a type of hyperactive neurovascular compression syndrome. However, the response rate of microvascular decompression for tinnitus varies from 40 to 77%, and the tinnitus-free rate is lower than the response rate [2–5]. In contrast, an interesting report about tinnitus accompanied by HFS has been published. Ryu et al. investigated the results of microvascular decompression for tinnitus accompanied by HFS. Tinnitus in 7 of 10 (70%) patients was completely resolved after surgery, which is comparable to the surgical result for HFS and trigeminal neuralgia . This unexpectedly high success rate may be related to the differences in clinical characteristics of patients with HFS in whom offending vessels run very close to the cochlear nerve. However, neurovascular compression has been evident on MRI in tinnitus patients without HFS in other reports. Therefore, the pathophysiologic mechanism of tinnitus accompanied by HFS may be different from the pathophysiological mechanism of tinnitus alone.
Initially, we assumed that the pathophysiological mechanism of tinnitus accompanied by HFS might be quite similar to the two suggested pathophysiological mechanisms of hyperactive neurovascular compression syndrome, ephaptic transmission and hyperactive cranial nerve nucleus and/or higher brain structure. If tinnitus accompanied by HFS is caused by ephaptic transmission of the cochlear nerve, then MEG for these patients should have shown decreased auditory cortical activity and a delayed latency from the auditory stimulus and cortical evoked field. However, MEG results of the AEF waveform for our patients with tinnitus accompanied by HFS showed simultaneously increased auditory cortical activity and decreased N100m latency on the HFS side compared with patients with HFS without tinnitus (Tables 2 and 3). This result suggests that tinnitus accompanied by HFS is unlikely to be caused by ephaptic transmission of the cochlear nerve by neurovascular compression. Therefore, hyperactivity and hyper-conductivity of the central auditory nervous system may play a key role in the pathophysiological mechanism .
A recent study was published about normal-hearing patients with tinnitus. In this study, the authors observed a shortening of the I-V latency and enlarged Na and Pa amplitudes, and concluded that the cause of tinnitus in these patients seemed to have originated from the central nervous system . Although the patients in that study did not have HFS, the tinnitus conditions were similar to our patients. The results of our study suggest that tinnitus may originate in the central nervous system, rather than the cranial nerve or the root entry zone.
Although the pathophysiology of tinnitus is still controversial, an interesting theory regarding the pathophysiological mechanism of tinnitus has been introduced recently. According to the theory, the dorsal cochlear nucleus in the pons, which is modulated by multi-sensory input, is a strong candidate for the origin of tinnitus [16–18]. Multi-sensory input can affect dorsal cochlear nucleus granule cells, leading to changes in dorsal cochlear nucleus principal cells . Thus, sensory stimuli can modulate cochlear function and may be the cause of tinnitus. Further support for the relationship between sensory stimuli and tinnitus is found in patients with tinnitus who are treated with botulinum toxin. Abnormal movement in the head and neck area can be associated with tinnitus, and this type of tinnitus is successfully cured with botulinum toxin injections into the affected muscle [20, 21].
According to our MEG results and recent theories, hyperactivity of the dorsal cochlear nucleus may be one of the major pathophysiological mechanisms of tinnitus accompanied by HFS. In our series, one of eight tinnitus patients, who had high-pitch continuous tinnitus accompanied by HFS, continued to suffer from tinnitus even though there was no evidence of facial spasm after microvascular decompression. These results are comparable with previous outcome reports in which 2 out of 10 patients continued to experience tinnitus after successful microvascular decompression for HFS, although some of these patients experienced a decrease in hearing ability prior to surgery . An irreversible change in the central auditory nervous system may be attributable to the symptoms of these patients, and further study might be helpful in understanding this change.
Hyperactivity of the central auditory nervous system should also be considered in the pathophysiological mechanism of tinnitus accompanied by HFS. Hyperactivity of the dorsal cochlear nucleus may be induced by both neurovascular compression of the cochlear nerve and multi-sensory input from facial sensory stimuli. In our study, we could not conclude which factor had more influence on this hyperactivity. A further clinical trial, which involves controlling facial sensory input with botulinum toxic injections instead of microvascular decompression, will be used to determine the cause of central auditory hyperactivity.
The pathophysiologic mechanism of tinnitus accompanied by HFS in normal-hearing patients is still controversial. From our MEG data, we conclude that the origin of tinnitus in patients with HFS may not be the cranial nerve but the central auditory nervous system. Further investigation and clinical correlation are required to obtain more information.
Auditory evoked field
Equivalent current dipole
Magnetic resonance imaging.
This work was supported by the Korea Research Council of Fundamental Science and Technology (KRCF) through a Basic Research Project managed by the Korea Research Institute of Standards and Science (KRISS).
- Crummer RW, Hassan GA: Diagnostic approach to tinnitus. Am Fam Physician. 2004, 69: 120-126.PubMedGoogle Scholar
- Møller MB, Møller AR, Jannetta PJ, Jho HD: Vascular decompression surgery for severe tinnitus: selection criteria and results. Laryngoscope. 1993, 103 (4): 421-427. 10.1002/lary.5541030410.View ArticlePubMedGoogle Scholar
- Brookes GB: Vascular-decompression surgery for severe tinnitus. Am J Otol. 1996, 17 (4): 569-576.PubMedGoogle Scholar
- Vasama J, Moller MB, Moller AR: Microvascular decompression of the cochlear nerve in patients with severe tinnitus. Preoperative findings and operative outcome in 22 patients. Neurol Res. 1998, 20 (3): 242-248.PubMedGoogle Scholar
- Guevara N, Deveze A, Buza V, Laffont B, Magnan J: Microvascular decompression of cochlear nerve for tinnitus incapacity: pre-surgical data, surgical analyses and long-term follow-up of 15 patients. Eur Arch Otorhinolaryngol. 2008, 265 (4): 397-401. 10.1007/s00405-007-0471-1.View ArticlePubMedGoogle Scholar
- Ryu H, Yamamoto S, Sugiyama K, Uemura K, Nozue M: Neurovascular decompression of the eighth cranial nerve in patients with hemifacial spasm and incidental tinnitus: an alternative way to study tinnitus. J Neurosurg. 1998, 88 (2): 232-236. 10.3171/jns.1998.88.2.0232.View ArticlePubMedGoogle Scholar
- Ryu H, Yamamoto S, Sugiyama K, Nozue M: Neurovascular compression syndrome of the eighth cranial nerve. What are the most reliable diagnostic signs?. Acta Neurochir (Wien). 1998, 140 (12): 1279-1286. 10.1007/s007010050250.View ArticleGoogle Scholar
- De Ridder D, Menovsky T, Van de Heyning P: An otoneurosurgical approach to non-pulsatile and pulsatile tinnitus. B-ENT. 2007, 3 (Suppl 7): 79-86.PubMedGoogle Scholar
- De Ridder D, Vanneste S, Adriaensens I, Lee A, Van de Heyning P, Moller AR: Vascular compression of the cochlear nerve and tinnitus: a pathophysiological investigation. Acta Neurochir (Wien). 2012, 154 (5): 807-813. 10.1007/s00701-012-1307-3.View ArticleGoogle Scholar
- Møller A: The cranial nerve vascular compression syndrome: II. A review of pathophysiology. Acta Neurochir (Wien). 1991, 113 (1): 24-30.View ArticleGoogle Scholar
- Dandy WE: Concerning the cause of trigeminal neuralgia. Am J Surg. 1934, 24 (2): 447-455. 10.1016/S0002-9610(34)90403-7.View ArticleGoogle Scholar
- Haines SJ, Jannetta PJ, Zorub DS: Microvascular relations of the trigeminal nerve. J Neurosurg. 1980, 52 (3): 381-386. 10.3171/jns.1980.52.3.0381.View ArticlePubMedGoogle Scholar
- Barker FG, Jannetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD: Microvascular decompression for hemifacial spasm. J Neurosurg. 1995, 82 (2): 201-210. 10.3171/jns.1995.82.2.0201.View ArticlePubMedGoogle Scholar
- Barker FG, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD: The long-term outcome of microvascular decompression for trigeminal neuralgia. N Eng J Med. 1996, 334 (17): 1077-1084. 10.1056/NEJM199604253341701.View ArticleGoogle Scholar
- Singh S, Munjal S, Panda N: Comparison of auditory electrophysiological responses in normal-hearing patients with and without tinnitus. J Laryngol Otol. 2011, 125 (7): 668-672. 10.1017/S0022215111000569.View ArticlePubMedGoogle Scholar
- Shore S, Koehler S, Oldakowski M, Hughes L, Syed S: Dorsal cochlear nucleus responses to somatosensory stimulation are enhanced after noise‒induced hearing loss. Eur J Neurosci. 2008, 27 (1): 155-168.View ArticlePubMedPubMed CentralGoogle Scholar
- Dehmel S, Pradhan S, Koehler S, Bledsoe S, Shore S: Noise Overexposure Alters Long-Term Somatosensory-Auditory Processing in the Dorsal Cochlear Nucleus—Possible Basis for Tinnitus-Related Hyperactivity?. J Neurosci. 2012, 32 (5): 1660-1671. 10.1523/JNEUROSCI.4608-11.2012.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang H, Brozoski TJ, Caspary DM: Inhibitory neurotransmission in animal models of tinnitus: maladaptive plasticity. Hear Res. 2011, 279: 111-117. 10.1016/j.heares.2011.04.004.View ArticlePubMedPubMed CentralGoogle Scholar
- Pilati N, Ison MJ, Barker M, Mulheran M, Large CH, Forsythe ID, Matthias J, Hamann M: Mechanisms contributing to central excitability changes during hearing loss. Proc Natl Acad Sci. 2012, 109 (21): 8292-8297. 10.1073/pnas.1116981109.View ArticlePubMedPubMed CentralGoogle Scholar
- Scolozzi P, Carrera E, Jaques B, Kuntzer T: Successful treatment of a postpolio tinnitus with type a botulinum toxin. Laryngoscope. 2005, 115 (7): 1288-1290. 10.1097/01.MLG.0000165371.98079.BD.View ArticlePubMedGoogle Scholar
- Stidham KR, Solomon PH, Roberson JB: Evaluation of botulinum toxin A in treatment of tinnitus. Otolaryngol Head Neck Surg. 2005, 132 (6): 883-889. 10.1016/j.otohns.2005.02.015.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/13/42/prepub